- Exendin-4 alleviates β-Amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer's disease
Xiangwei Song et al, 2022, Frontiers in Aging Neuroscience CrossRef - Liraglutide ameliorates diabetes-associated cognitive dysfunction via rescuing autophagic flux
Meng Zhang et al, 2021, Journal of Pharmacological Sciences CrossRef - Exendin‐4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease
Aanchal Verma et al, 2024, Chemical Biology & Drug Design CrossRef - Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
Fanjing Kong et al, 2023, Frontiers in Pharmacology CrossRef - Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
Xiao‐Yu Liu et al, 2021, European Journal of Neuroscience CrossRef - GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice
Meltem Donmez Kutlu et al, 2023, Behavioural Brain Research CrossRef - Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
A Young Sim et al, 2021, Frontiers in Neuroscience CrossRef - GLP-1’s role in neuroprotection: a systematic review
Damla Erbil et al, 2019, Brain Injury CrossRef - Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Jeffrey Cummings et al, 2022, European Journal of Neuroscience CrossRef - The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du et al, 2022, Frontiers in Endocrinology CrossRef - Effect of DPP-4 inhibitor on elderly patients with T2DM combined with MCI
Jujun Xue et al, 2019, Experimental and Therapeutic Medicine CrossRef - Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1–42)-induced cognitive deficit rats
Debapriya Garabadu et al, 2019, Neurochemistry International CrossRef - Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β
Mei Zhou et al, 2019, Biochemical and Biophysical Research Communications CrossRef - DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
Shuyi Chen et al, 2019, Neuropharmacology CrossRef - Gastrointestinal hormones in regulation of memory
Anwesha Mandal et al, 2018, Peptides CrossRef - Aβ1–42 oligomer induces alteration of tight junction scaffold proteins via RAGE-mediated autophagy in bEnd.3 cells
Yuanjin Chan et al, 2018, Experimental Cell Research CrossRef - Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease
Syed Obaidur Rahman et al, 2020, European Journal of Pharmacology CrossRef - Microcurrent therapy as the nonpharmacological new protocol against Alzheimer’s disease
Eun Ho Kim et al, 2024, Frontiers in Aging Neuroscience CrossRef - The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders
Jenq-Lin Yang et al, 2017, International Journal of Molecular Sciences CrossRef - Critical Review of the Alzheimer’s Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
Julio A. Flores-Cuadra et al, 2021, Journal of Alzheimer's Disease CrossRef - Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer’s disease
Mingcui Zheng et al, 2021, 3 Biotech CrossRef - Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review
Benjamin Kioussis et al, 2021, Ageing Research Reviews CrossRef - Exendin-4 Prevents Memory Loss and Neuronal Death in Rats with Sporadic Alzheimer-Like Disease
Adriana M. Zago et al, 2024, Molecular Neurobiology CrossRef